← Back
Data updated: Mar 29, 2026
QUANTUM PHARMICS
NeurologyCardiovascular
Generics
QUANTUM PHARMICS is a generic drug manufacturer focused on Neurology, Cardiovascular.
1985
Since
25
Drugs
-
Trials
131
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
NYSTATIN 2026-02-05
HALOPERIDOL 2025-12-18
HYDROXYZINE HYDROCHLORIDE 2025-12-16
TRIAMTERENE AND HYDROCHLOROTHIAZIDE 2025-10-21
Labeling
TRIAMTERENE AND HYDROCHLOROTHIAZIDE 2025-10-21
Labeling
CLORAZEPATE DIPOTASSIUM 2025-08-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 50%
2 drugs
Cardiovascular 50%
2 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (5)
Discontinued (20)
TRAZODONE HYDROCHLORIDE HALOPERIDOL HYDROXYZINE HYDROCHLORIDE CLORAZEPATE DIPOTASSIUM HYDRALAZINE HYDROCHLORIDE BUTALBITAL, ASPIRIN AND CAFFEINE FENOPROFEN CALCIUM OXYBUTYNIN CHLORIDE DOXYLAMINE SUCCINATE ZAXOPAM MINODYL TRIALODINE Q-PAM CLOPRA-"YELLOW" Q-GESIC CLOPRA TEMAZ LORAZ MECLODIUM PHENTERMINE RESIN 30
Company Info
- First Approval
- 1985-10-28
- Latest
- 1989-06-28
- Applications
- 63